News
Blood-oxygenating device may replace ventilator for severely ill lung patients
Pittsburgh Post-Gazette
Nick Kuhn, chief operating officer of ALung Technologies Inc., expects to receive a phone call within the next few weeks that could signal big things for the small South Side company.
The call may come from the Artemis Health Institute in Gurgaon, India, or one of five hospitals in Germany where doctors are preparing to use ALung’s Hemolung respiratory assist device on a human patient for the first time.
If all goes well, ALung could be selling Hemolung to hospitals throughout Europe a year from now, and in the United States by late 2012.
The Hemolung does for patients with chronic respiratory problems what hemodialysis does for patients with kidney disease, intervening to support a patient through a possibly life-threatening infection without the need for a ventilator.
